Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus
- 1 October 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 155 (3), 313-316
- https://doi.org/10.1016/0014-2999(88)90521-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390Journal of Neural Transmission, 1988
- Effect of chronic treatment with SCH 23390 and haloperidol on spontaneous activity of dopamine neurones in substantia nigra pars compacta (SNC) and ventral tegmental area (VTA) in ratsEuropean Journal of Pharmacology, 1988
- Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the ratEuropean Journal of Pharmacology, 1986
- The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptorsEuropean Journal of Pharmacology, 1986
- EFFECTS OF CHRONIC SCH23390 TREATMENT ON THE BIOCHEMICAL AND BEHAVIORAL PROPERTIES OF D1 AND D2 DOPAMINE-RECEPTORS - POTENTIATED BEHAVIORAL-RESPONSES TO A D2 DOPAMINE AGONIST AFTER SELECTIVE D1 DOPAMINE RECEPTOR UP-REGULATION1986
- Increased catecholamine metabolism in the locus coeruleus of young spontaneously hypertensive ratsBrain Research, 1986
- Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamineBrain Research, 1986
- Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390European Journal of Pharmacology, 1985
- Chronic haloperidol inactivates brain noradrenergic neuronsBrain Research, 1985
- SCH-23390, A POTENTIAL BENZAZEPINE ANTI-PSYCHOTIC WITH UNIQUE INTERACTIONS ON DOPAMINERGIC SYSTEMS1983